Gallo and Wine: The Impact May Be Never Ending
It's not a perfect irony, but it's interesting: It is being reported that researchers at the Ernest Gallo Clinic and Research Center in San Francisco are moving closer to not only understanding alcohol and nicotine addiction, but toward developing drugs that inhibit the dopamine-induced pleasure our brains experience when alcohol and nicotine hit it. This development would, presumably, lead to severely lessening the addictive impact that alcohol and nicotine might have on a person.
Call me insensitive or innappropriate, but upon reading this very good bit of news, I am prompted to wonder if it will help or hurt the wine industry when alcohol's addictive qualities are so masked by simple drugs. Will people drink more or less wine?
On the one hand, if alcohol addiction is but a very unlikely reaction to imbibing, perhaps folks will drink more; perhaps those who don't drink for fear of coming under the influence of alcohol's addictive reach will no longer fear this and indulge.
On the other hand, perhaps those who now drink to excess because of an addiction, will be able to finally move away from the excessive consumption and they will drink less wine.
Better yet, perhaps both of these reactions will be the result of the development of a "medications that could be used "to take the edge off of addiction by helping people get over some of their reward craving," as the researchers put it.
Ernest and Julio Gallo provided the means by which America would become a wine drinking country. Perhaps they will also have provided the means by which Americans (and others) become better composed and responsible drinkers. Again, it's not a perfect irony, but it is head-nodding, and smirk-inducing circumstance.